Back to News
Market Impact: 0.28

2 Stocks to Buy if You Think $100 Oil Will Last

Source: The Motley Fool

Energy Markets & PricesCompany FundamentalsAnalyst EstimatesCapital Returns (Dividends / Buybacks)Corporate Guidance & Outlook

Brent and WTI crude recently rose above $100 per barrel amid the Iran war, improving the cash-flow outlook for oil producers Occidental Petroleum and Chevron. Oxy, a more upstream-focused oil-price play, has a $40/bbl WTI corporate breakeven and is expected to deliver 175% adjusted EPS growth in 2026; its shares are up 43% year-to-date and trade at 16x forward earnings. Chevron offers greater downstream diversification, requires Brent above $50/bbl to fund capex and dividends through 2030, targets 2%-3% annual production growth through decade-end, and is expected to grow 2026 adjusted EPS by 122%.

Analysis

The relative trade is more compelling than an outright energy beta purchase after the sector’s sharp rerating: OXY should retain the highest incremental cash-flow sensitivity to WTI, while CVX’s refining and marketing exposure offsets part of upstream realization gains as crude-input costs rise. OXY’s equity also carries greater balance-sheet and execution sensitivity, so sustained $90-$100+ WTI can drive disproportionate deleveraging/buyback upside, but a rapid price normalization would compress its earnings multiple faster than CVX’s. The article’s assertion regarding OxyChem should be independently verified before relying on any claimed simplification of OXY’s business mix.

Over the next 1-3 months, the key variable is not spot crude but the prompt-to-12-month WTI/Brent curve. A sustained backwardated curve would validate a physical supply deficit and support upward revisions to 2027 cash-flow estimates; a geopolitical spike that leaves deferred crude flat would favor taking profits in high-beta producers. CVX is structurally better positioned for a 6-18 month range-bound oil environment because of dividend durability, LNG and downstream diversification, whereas OXY requires stronger commodity pricing to justify continued relative outperformance.

Consensus is likely underweighting demand-side and policy responses if retail fuel prices remain elevated for multiple months. Higher cracks initially cushion refiners, but demand destruction, SPR/diplomatic supply responses, or a ceasefire can unwind the oil premium abruptly. The clean falsifier for the OXY-over-CVX thesis is a sustained decline in 6-12 month WTI below $75/bbl, or OXY signaling that incremental cash flow is being redirected to capex/debt rather than shareholder returns.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.48

Ticker Sentiment

CVX0.58
OXY0.72

Key Decisions for Investors

  • Initiate a 1-3 month pair trade: long OXY / short CVX in equal dollar amounts only if front-month WTI remains above $90 and the 12-month strip is above $80. Target 10-15% relative upside; exit if the pair underperforms by 7% or deferred WTI breaks $75.
  • For lower-volatility energy exposure, accumulate CVX on broad-market weakness rather than chase a crude-price spike. The intended 6-18 month return driver is capital return plus production growth, with downside protection relative to E&Ps if oil retraces; reassess on a dividend/buyback reduction or material Guyana/Kazakhstan execution setback.
  • Avoid adding outright OXY after a further parabolic move unless quarterly results demonstrate cash flow conversion and net-debt reduction at the prevailing strip. Monitor realized WTI differentials, production guidance, and capital allocation; these matter more than headline Brent prices.
  • Use XLE as the liquid sector hedge against any long OXY position if geopolitical headline risk rises. A ceasefire, coordinated supply release, or prompt crude premium collapsing while deferred prices hold would be the signal to reduce producer beta rather than add.

More News

From AllMind Research

Browse all research